Menu Search
Equities

Sotera Health Co

SH5:MUN

Sotera Health Co

Actions
  • Price (EUR)14.70
  • Today's Change-0.50 / -3.29%
  • Shares traded--
  • 1 Year change+21.49%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 16:26 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Sotera Health Co grew revenues 4.54% from 1.00bn to 1.05bn while net income improved from a loss of 233.57m to a gain of 51.38m.
Gross margin55.16%
Net profit margin6.31%
Operating margin25.91%
Return on assets2.29%
Return on equity16.63%
Return on investment2.44%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Sotera Health Co fell by 94.64m. Cash Flow from Financing totalled 265.96m or 25.35% of revenues. In addition the company used 147.73m for operations while cash used for investing totalled 214.91m.
Cash flow per share0.8255
Price/Cash flow per share19.20
Book value per share1.66
Tangible book value per share-3.46
More ▼

Balance sheet in USDView more

Sotera Health Co has a Debt to Total Capital ratio of 83.19%, a lower figure than the previous year's 605.61%.
Current ratio2.88
Quick ratio2.61
Total debt/total equity4.95
Total debt/total capital0.8319
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.